Join
Live feed
·
INSIDERFilingvia Quantisnow
Tyra Biosciences Inc. logo

Director Kaplan Gilla sold $93,700 worth of shares (9,578 units at $9.78), decreasing direct ownership by 25% to 28,231 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TYRA· Tyra Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TYRA (Tyra Biosciences Inc.) and more on Quantisnow.